97 related articles for article (PubMed ID: 19522652)
1. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues.
Uyeki TM
Clin Infect Dis; 2009 Jul; 49(2):279-90. PubMed ID: 19522652
[TBL] [Abstract][Full Text] [Related]
2. Drivers for a pandemic due to avian influenza and options for One Health mitigation measures.
; ; Adlhoch C; Alm E; Enkirch T; Lamb F; Melidou A; Willgert K; Marangon S; Monne I; Stegeman JA; Delacourt R; Baldinelli F; Broglia A
EFSA J; 2024 Apr; 22(4):e8735. PubMed ID: 38576537
[TBL] [Abstract][Full Text] [Related]
3. Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond.
Faist A; Janowski J; Kumar S; Hinse S; Çalışkan DM; Lange J; Ludwig S; Brunotte L
Cells; 2022 Jul; 11(14):. PubMed ID: 35883640
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of a combination of human intracellular and extracellular antibodies against the highly pathogenic avian influenza H5N1 virus.
Jin Q; Yao Z; Liu F; Di Y; Gao J; Zhang X
Hum Vaccin Immunother; 2022 Dec; 18(1):2035118. PubMed ID: 35240918
[TBL] [Abstract][Full Text] [Related]
5. Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis.
Chen X; Wang W; Wang Y; Lai S; Yang J; Cowling BJ; Horby PW; Uyeki TM; Yu H
BMC Med; 2020 Dec; 18(1):377. PubMed ID: 33261599
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical prognosis of human infections with avian influenza A(H7N9) viruses in China after hospitalization.
Wang Q; Jiang H; Xie Y; Zhang T; Liu S; Wu S; Sun Q; Song S; Wang W; Deng X; Ren L; Qin T; Horby P; Uyeki T; Yu H
EClinicalMedicine; 2020 Mar; 20():100282. PubMed ID: 32300739
[TBL] [Abstract][Full Text] [Related]
7. [Influenza today and in the future].
Panning M
Pneumologe (Berl); 2013; 10(5):314-325. PubMed ID: 32288709
[TBL] [Abstract][Full Text] [Related]
8. Pre-Treatment with Zirconia Nanoparticles Reduces Inflammation Induced by the Pathogenic H5N1 Influenza Virus.
Huo C; Xiao J; Xiao K; Zou S; Wang M; Qi P; Liu T; Hu Y
Int J Nanomedicine; 2020; 15():661-674. PubMed ID: 32099358
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.
Kandasamy M; Furlong K; Perez JT; Manicassamy S; Manicassamy B
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075925
[TBL] [Abstract][Full Text] [Related]
10. The Epidemiology, Virology, and Pathogenicity of Human Infections with Avian Influenza Viruses.
Wang D; Zhu W; Yang L; Shu Y
Cold Spring Harb Perspect Med; 2021 Apr; 11(4):. PubMed ID: 31964651
[TBL] [Abstract][Full Text] [Related]
11. Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost.
Levine MZ; Holiday C; Jefferson S; Gross FL; Liu F; Li S; Friel D; Boutet P; Innis BL; Mallett CP; Tumpey TM; Stevens J; Katz JM
NPJ Vaccines; 2019; 4():22. PubMed ID: 31149353
[TBL] [Abstract][Full Text] [Related]
12. A review of H5Nx avian influenza viruses.
Nuñez IA; Ross TM
Ther Adv Vaccines Immunother; 2019; 7():2515135518821625. PubMed ID: 30834359
[TBL] [Abstract][Full Text] [Related]
13. Innate Immune Responses to Avian Influenza Viruses in Ducks and Chickens.
Evseev D; Magor KE
Vet Sci; 2019 Jan; 6(1):. PubMed ID: 30634569
[TBL] [Abstract][Full Text] [Related]
14. Zoonotic Influenza and Human Health-Part 1: Virology and Epidemiology of Zoonotic Influenzas.
Goneau LW; Mehta K; Wong J; L'Huillier AG; Gubbay JB
Curr Infect Dis Rep; 2018 Aug; 20(10):37. PubMed ID: 30069735
[TBL] [Abstract][Full Text] [Related]
15. Dissecting host cell death programs in the pathogenesis of influenza.
Downey J; Pernet E; Coulombe F; Divangahi M
Microbes Infect; 2018; 20(9-10):560-569. PubMed ID: 29679740
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive study on cellular RNA editing activity in response to infections with different subtypes of influenza a viruses.
Cao Y; Cao R; Huang Y; Zhou H; Liu Y; Li X; Zhong W; Hao P
BMC Genomics; 2018 Jan; 19(Suppl 1):925. PubMed ID: 29363430
[TBL] [Abstract][Full Text] [Related]
17. Recent outbreaks of highly pathogenic avian influenza viruses in South Korea.
Kim HK; Jeong DG; Yoon SW
Clin Exp Vaccine Res; 2017 Jul; 6(2):95-103. PubMed ID: 28775973
[TBL] [Abstract][Full Text] [Related]
18. Geldanamycin Reduces Acute Respiratory Distress Syndrome and Promotes the Survival of Mice Infected with the Highly Virulent H5N1 Influenza Virus.
Wang C; Liu P; Luo J; Ding H; Gao Y; Sun L; Luo F; Liu X; He H
Front Cell Infect Microbiol; 2017; 7():267. PubMed ID: 28664154
[TBL] [Abstract][Full Text] [Related]
19. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
Sun X; Belser JA; Pulit-Penaloza JA; Creager HM; Guo Z; Jefferson SN; Liu F; York IA; Stevens J; Maines TR; Jernigan DB; Katz JM; Levine MZ; Tumpey TM
Virology; 2017 Aug; 508():164-169. PubMed ID: 28554058
[TBL] [Abstract][Full Text] [Related]
20. Influenza A Viruses Replicate Productively in Mouse Mastocytoma Cells (P815) and Trigger Pro-inflammatory Cytokine and Chemokine Production through TLR3 Signaling Pathway.
Meng D; Huo C; Wang M; Xiao J; Liu B; Wei T; Dong H; Zhang G; Hu Y; Sun L
Front Microbiol; 2016; 7():2130. PubMed ID: 28127293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
